144 related articles for article (PubMed ID: 17365276)
1. Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes.
Adrian JE; Kamps JA; Poelstra K; Scherphof GL; Meijer DK; Kaneda Y
J Drug Target; 2007 Jan; 15(1):75-82. PubMed ID: 17365276
[TBL] [Abstract][Full Text] [Related]
2. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K
Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581
[TBL] [Abstract][Full Text] [Related]
3. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
[TBL] [Abstract][Full Text] [Related]
4. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA
J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
[TBL] [Abstract][Full Text] [Related]
5. New vector innovation for drug delivery: development of fusigenic non-viral particles.
Kaneda Y
Curr Drug Targets; 2003 Nov; 4(8):599-602. PubMed ID: 14577648
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K
Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
[TBL] [Abstract][Full Text] [Related]
8. HVJ liposomes and HVJ envelope vectors.
Kaneda Y
Cold Spring Harb Protoc; 2011 Oct; 2011(10):1281-9. PubMed ID: 21969614
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells.
Zhang J; Zhang QS; Chen XM; Tian GY
Glycoconj J; 2002 Jul; 19(6):423-9. PubMed ID: 14707489
[TBL] [Abstract][Full Text] [Related]
10. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
Hagens WI; Mattos A; Greupink R; de Jager-Krikken A; Reker-Smit C; van Loenen-Weemaes A; Gouw IA; Poelstra K; Beljaars L
Pharm Res; 2007 Mar; 24(3):566-74. PubMed ID: 17245650
[TBL] [Abstract][Full Text] [Related]
11. Development of HVJ envelope vector and its application to gene therapy.
Kaneda Y; Yamamoto S; Nakajima T
Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
[TBL] [Abstract][Full Text] [Related]
12. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.
van Beuge MM; Prakash J; Lacombe M; Post E; Reker-Smit C; Beljaars L; Poelstra K
Pharm Res; 2011 Aug; 28(8):2045-54. PubMed ID: 21442374
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
[TBL] [Abstract][Full Text] [Related]
14. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
Patel G; Kher G; Misra A
J Drug Target; 2012 Feb; 20(2):155-65. PubMed ID: 21913877
[TBL] [Abstract][Full Text] [Related]
16. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system.
Kaneda Y; Nakajima T; Nishikawa T; Yamamoto S; Ikegami H; Suzuki N; Nakamura H; Morishita R; Kotani H
Mol Ther; 2002 Aug; 6(2):219-26. PubMed ID: 12161188
[TBL] [Abstract][Full Text] [Related]
17. Development of liposomes and pseudovirions with fusion activity for efficient gene delivery.
Kaneda Y
Curr Gene Ther; 2011 Dec; 11(6):434-41. PubMed ID: 22023472
[TBL] [Abstract][Full Text] [Related]
18. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
[TBL] [Abstract][Full Text] [Related]
19. Disease-induced drug targeting using novel peptide-ligand albumins.
Meijer DK; Beljaars L; Molema G; Poelstra K
J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
[TBL] [Abstract][Full Text] [Related]
20. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]